LFB BIOMANUFACTURING is a CDMO specialising in the manufacture of recombinant proteins and monoclonal antibodies.
AN EXPERIENCED TEAM, WORKING WITH AGILITY AND UNDERSTANDING CHALLENGES OF BIOLOGICALS: LFB BIOMANUFACTURING has strong assets for your projects
In November 2022 the leadership team of LFB BIOMANUFACTURING met with aim to precise the strategic path of the company, referred to as ESCAPE30
Why will you select LFB BIOMANUFACTURING as you preferred partner?
LFB group, a pharmaceutical company specialising in biological medicinal products
Two CLD platforms are currently available at LFB BIOMANUFACTURING: a CHO-S (Life Technology) platform, and EMABling® proprietary platform.
A proprietary platform for monoclonal antibodies with enhanced ADCC
Services for process development and scale-up
GMP Manufacturing services for recombinant medicinal products
Flexibility, disposable-oriented, LFB BIOMANUFACTURING’s commitments for tomorrow
Des médicaments commercialisés dans près de 60 pays
Accueil › Actualités
Retrouvez les actualités, les communiqués de presse de LFB BIOMANUFACTURING.
